Skip to main content

Advertisement

SpringerLink
Log in

Adherence with Use of Oral Agents in the Treatment of Chronic Hepatitis B

  • Hepatitis B: Therapeutics (P Martin, Section Editor)
  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

Oral nucleos(t)ide agents are used to prevent major complications of chronic hepatitis B infection, such as the development of cirrhosis, hepatic decompensation, hepatocellular carcinoma, and death. To achieve benefit, long-term, and potentially, life-long, antiviral therapy is needed to maintain adequately suppressed hepatitis B viral loads, and therefore, medication adherence is essential. However, long-term therapy may also be complicated by virological breakthrough and the development of antiviral resistance. This will be a brief review of the several recent studies that have examined how patient adherence affects virological outcomes, as well as the potential factors that can affect adherence to antiviral therapy for hepatitis B. infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Lavanchy D, Hepatitis B. virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97–107.

    Article  PubMed  CAS  Google Scholar 

  2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005;34(6):1329–39.

    Article  PubMed  Google Scholar 

  3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2.

    Article  PubMed  Google Scholar 

  4. Papatheodoridis GV, Manolakopoulos S. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. J Hepatol. 2009;51(1):226–7.

    Article  PubMed  Google Scholar 

  5. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6(12):1315–41.

    Article  PubMed  CAS  Google Scholar 

  6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  PubMed  CAS  Google Scholar 

  7. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf

  8. Parker-Pope T. Keeping score on how you take your medicine. New York: The New York Times; 2011. http://well.blogs.nytimes.com/2011/06/20/keeping-score-on-how-you-take-your-medicine/

  9. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335(14):1001–9.

    Article  PubMed  CAS  Google Scholar 

  10. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339(19):1349–57.

  11. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–7.

    Article  PubMed  Google Scholar 

  12. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6(5):566–73.

    Article  PubMed  Google Scholar 

  13. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880–3.

    Article  PubMed  Google Scholar 

  14. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7):722–32.

    Article  PubMed  Google Scholar 

  15. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239–45.

    PubMed  Google Scholar 

  16. Fung V, Huang J, Brand R, Newhouse JP, Hsu J. Hypertension treatment in a medicare population: adherence and systolic blood pressure control. Clin Ther. 2007;29(5):972–84.

    Article  PubMed  Google Scholar 

  17. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.

    Article  PubMed  CAS  Google Scholar 

  18. Li JZ PR, Ribaudo H, Svarovskaia ES, Kozal MJ, Hullsiek KH et al. Relationship between Minority NNRTI resistance mutations, adherence, and the risk of virologic failure. AIDS. 2011 Nov 16 [Epub ahead of print]

  19. Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41(3):385–92.

    Article  PubMed  Google Scholar 

  20. Kitahata MM, Reed SD, Dillingham PW, Van Rompaey SE, Young AA, Harrington RD, et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS. 2004;15(12):803–10.

    Article  PubMed  Google Scholar 

  21. • Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol. 2011;54(1):12–8. This is the first large-scale assessment of adherence with oral antiviral therapy against HBV outside of a clinical trial.

    Article  PubMed  CAS  Google Scholar 

  22. • Hilleret MN, Larrat S, Stanke-Labesque F, Leroy V. Does adherence to hepatitis B antiviral treatment correlate with virological response and risk of breakthrough? J Hepatol. 2011;55(6):1468–9. This study utilized direct assessment of adherence through plasma drug levels.

    Article  PubMed  Google Scholar 

  23. • Hongthanakorn C, Chotiyaputta W, Oberhelman K, Fontana RJ, Marrero JA, Licari T et al. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology. 2011;53(6):1854–63. This showed a large discrepancy between the incidence of virological breakthrough and viral resistance during long-term antiviral use.

    Article  PubMed  Google Scholar 

  24. Chotiyaputta W OK, Hongthanakorn C, Conjeevaram HS, Fontana RJ, Licari T et al. Correlation between self-reported adherence to nucleos(t)ide analogue (NUC) therapy for chronic hepatitis B (CHB) and virological breakthroughs (VBT) [Abstract]. Hepatology. 2010(52):542A.

  25. Ha NB, Garcia RT, Trinh HN, Chaung KT, Nguyen HA, Nguyen KK, et al. Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. Dig Dis Sci. 2011;56(8):2423–31.

    Article  PubMed  Google Scholar 

  26. Kamezaki H, Kanda T, Wu S, Nakamoto S, Arai M, Maruyama H, et al. Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication. Scand J Gastroenterol. 2011;46(9):1111–7.

    Article  PubMed  CAS  Google Scholar 

  27. • Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol. 2009;51(2):403–10. Reviewed multiple factors that may affect adherence to oral antiviral therapy, particularly in Asia.

    Article  PubMed  Google Scholar 

  28. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106(2):148–55.

    Article  PubMed  Google Scholar 

  29. Upadhyaya N, Chang R, Davis C, Conti MC, Salinas-Garcia D, Tang H. Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians. Postgrad Med. 2010;122(5):165–75.

    Article  PubMed  Google Scholar 

  30. • Ng CJ, Low WY, Wong LP, Sudin MR, Mohamed R. Uncovering the experiences and needs of patients with chronic hepatitis B infection at diagnosis: a qualitative study. Asia Pac J Public Health. 2011. This qualitatively examined psychosocial factors that may affect adherence to oral antiviral therapy.

  31. Jonikas MA, Mandl KD. Surveillance of medication use: early identification of poor adherence. J Am Med Inform Assoc. 2011.

  32. Ting TV KD, Nelson S, Cortina S, Pendl J, Budhani S, et al. Usefulness of Cellular Text Messaging for Improving Adherence Among Adolescents and Young Adults with Systemic Lupus Erythematosus. J Rheumatol. 2011 Nov 15 [Epub ahead of print]

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Liver Center, Virginia Mason Medical Center, 1100 Ninth Avenue, PO Box 900, Mailstop C3-GAS, Seattle, WA, 98111, USA

    Maximilian Lee

Authors
  1. Maximilian Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maximilian Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, M. Adherence with Use of Oral Agents in the Treatment of Chronic Hepatitis B. Curr Hepatitis Rep 11, 70–74 (2012). https://doi.org/10.1007/s11901-012-0125-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-012-0125-7

Keywords

Search

Navigation